Immunophenotypic and Clinical Characteristics of SET-CAN Fusion Gene Positive Acute Leukemia Patients.
10.19746/j.cnki.issn.1009-2137.2023.06.007
- Author:
Song-Ya LIU
1
;
Li ZHU
1
;
Chun-Yan WANG
1
;
Cheng HE
1
;
Shu-Juan YI
1
;
Li MENG
1
;
Min XIAO
2
;
Xia MAO
3
Author Information
1. Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
2. Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.E-mail: xiaomin@tjh.tjmu.edu.cn.
3. Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.E-mail: maoxia2009@163.com.
- Publication Type:Journal Article
- Keywords:
acute leukemia;
differential diagnosis;
immunophenotype;
prognosis
- MeSH:
Humans;
Leukemia, Myeloid, Acute/pathology*;
Bone Marrow/pathology*;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics*;
Antigens, CD34;
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma;
Immunophenotyping
- From:
Journal of Experimental Hematology
2023;31(6):1639-1646
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the flow immunophenotype and clinical characteristics of leukemia patients with positive SET-CAN fusion gene.
METHODS:A total of 7 newly diagnosed acute leukemia patients with SET-CAN fusion gene admitted to Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology from February 2016 to February 2020 were collected. Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the expression of SET-CAN fusion gene. The immunophenotype was detected by four-color flow cytometry. The case information of 17 literatures published at home and abroad was extracted for statistical analysis.
RESULTS:Among the 7 patients, 2 cases were diagnosed as mixed phenotype acute leukemia (MPAL), 2 cases as acute myeloid leukemia (AML), and 3 cases as T-acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL). Leukemia cells in bone marrow specimens of all cases expressed or partially expressed CD34, CD33 and CD7. CD5 and cytoplasmic CD3 were expressed in 5 patients except 2 patients diagnosed with AML. Bone marrow and lymph node specimens were both detected in 2 patients, and the immunophenotypes of the two specimens were not completely consistent, with differences in lineage or maturity related markers. Two patients with MPAL showed differentiated response to treatment. One AML patient gave up treatment, and another AML patient with FLT3-ITD gene mutation had a poor prognosis. All three T-ALL/LBL patients maintained a long duration of remission after induced remission, and one case underwent allogeneic hematopoietic stem cell transplantation.
CONCLUSIONS:There are common characteristics of immunophenotype in patients with positive SET-CAN fusion gene. Differential expression of immunophenotype in samples from different parts is observed in some cases. The prognosis of these diseases varies.
